Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Aclid logo — Helping scientists build safer and better biomanufactured pr...

Aclid

Helping scientists build safer and better biomanufactured products

Founded 2021 United States New York, United States 15 employees Seed Total: $3.30M Biopharma, Biotechnology +1

General Information

Company Name Aclid
Founded Year 2021
Location United States New York, United States
Employees 15
Industries Biopharma, Biotechnology, Life Sciences
Funding Stage Seed
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Aclid. To contact Aclid, visit aclid.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Aclid compare?

A PDF of Aclid and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Aclid soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Aclid

Aclid, founded in 2021, is positioned as a critical player in the Biopharma, Biotechnology, and Life Sciences sectors. Its platform enhances biosecurity and biosafety, ensuring efficient lab operations and compliance in environmental, health, and safety standards. Aclid's solutions are already trusted by leading life sciences companies and government bodies seeking responsible research methodologies.

Headquartered in the United States, Aclid recently secured a $3.30M seed investment led by 2048 Ventures and IA Ventures as of 01 October 2023. This financial boost underscores investor confidence in Aclid's ability to innovate and solve critical issues within the scientific community.

Overall, Aclid represents a promising opportunity for investors seeking to support and scale a company that is not only poised for growth but also essential for advancing safety in biomanufacturing processes.

Business keywords: biotechnology security, compliance automation, biosafety, biosecurity, lab operations, EH&S (Environmental Health and Safety), quality monitoring, gene synthesis verification, pathogen screening, DNA screening, RNA screening, compliance inspections, life sciences compliance, biomanufacturing safety, biotechnology risk management

Services & Products

Automated Biosecurity and Biosafety Compliance
Real-time Threat and Risk Profiling
Sanctions and Watchlist Screening
Collaborative Compliance Data Management
Advanced Sequence and Construct Analysis
Customer Assessment Automation

Target Customers

Biotechnology Companies Research Institutions Biosecurity Professionals Compliance Officers Laboratories Security Teams

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $3.30M 2
2048 Ventures IA Ventures
2048 Ventures, IA Ventures
01 Oct 2023
Seed Undisclosed 2
2048 Ventures Coalition Operators
2048 Ventures, Coalition Operators
01 Oct 2021

Latest News

View All
The US Is Cracking Down on Synthetic DNA — Wired
The US Is Cracking Down on Synthetic DNA
Wired May 06, 2024

Aclid Alternatives & Competitors

View All Alternatives
Aclid vs
AsedaSciences®
AsedaSciences® Switzerland

Helping scientists develop safer chemicals

11 employees
Biotechnology, Life Sciences
Aclid vs
Ganymede
Ganymede United States

Modern cloud platform to capture, automate, and analyze lab data.

Series A
47 employees
Biopharma, Enterprise Software
Aclid vs
MBL International Corporation
MBL International Corporation United States

MBL International provides high-quality products and solutions to advance life science research.

83 employees
Biotechnology, Health Care
View all alternatives

FAQ About Aclid

Helping scientists build safer and better biomanufactured products
Aclid was founded in 2021.
Aclid is headquartered in New York, United States.
Aclid operates in Biopharma, Biotechnology and Life Sciences. Its work centres on biotechnology security, compliance automation, biosafety and biosecurity. Its customers include Biotechnology Companies, Research Institutions and Biosecurity Professionals.
Aclid has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Service Fee.
Aclid has approximately 15 employees.
Aclid has completed 2 funding rounds, raising a total of $3.30M. The latest funding stage is Seed.
Aclid offers: Automated Biosecurity and Biosafety Compliance, Real-time Threat and Risk Profiling, Sanctions and Watchlist Screening, Collaborative Compliance Data Management, Advanced Sequence and Construct Analysis, Customer Assessment Automation.
Top alternatives and competitors to Aclid include AsedaSciences®, Ganymede, MBL International Corporation, BenchSci, Orrbitt Creative Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aclid and AsedaSciences® are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Aclid, https://bouncewatch.com/company/aclid, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes